Oncology Reports · 2006 · 15 citations · 14 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer BiomarkersCancer GenomicsColorectal CancerGenomic ImprintingMalignant NeoplasmsTumor MarkersGenomic Imprinting AlterationsImprinting AlterationsLoss Of Imprinting
To ascertain the implications of loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) for carcinogenesis, the precise frequency of LOI in colorectal carcinoma was examined using a laser capture microdissection method, and compared to the matched normal colorectal mucosa. LOI was examined by PCR-restriction fragment length polymorphism in combination with direct sequencing. The status was assigned as imprinting when PCR-RFLP showed only one band or sequence with a single peak, otherwise cases were classified as LOI. LOI was found in 13 of 24 informative cases of carcinoma (54%), which was higher than the ratios reported previously. LOI was also found in the normal colorectal mucosae in 14 cases (58%). The LOIs in carcinomas and in the normal mucosae were closely correlated: 10 of 13 LOI-positive carcinomas showed LOI in the matched normal mucosae. These results suggest that LOI of IGF2 in colorectal carcinoma and LOI in the background mucosa play important roles in carcinogenesis.
14
Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Hengmi Cui, Patrick Onyango, Sheri A. Brandenburg et al. · PubMed · 2002 · 392 citations · Full text